JANINE MARIE POPOT M.D.
Prescription History 1104847821
Obstetrics & Gynecology in Darien, CT
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for JANINE MARIE POPOT M.D., an active Obstetrics & Gynecology specialist practicing in Darien, CT. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 84 documented patient claims. Among these therapy options, the most frequently utilized medication is Estradiol, which accounts for 31 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other CT PrescribersVs. CT Avg |
|---|---|---|---|
| Estradiol | 31 | $100.59 | ≈ Typical |
About Estradiol: This medication is a female hormone (estrogen). Show more ▾ It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. In 2023, this provider wrote 31 Medicare prescriptions for Estradiol, about 82% of the volume of the typical Connecticut prescriber of this medication (38). Medicare paid an average of $100.59 per fill, versus $100.41 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 65.4 30-Day Fills standardized to 30-day supplies 1,962 Days of Medication total across all patients in 2023 | |||
| Estradiol (Once Weekly)Estradiol | 17 | $80.36▼ below CT avg | ≈ Typical |
About Estradiol (Once Weekly): This medication is a female hormone (estrogen). Show more ▾ It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. In 2023, this provider wrote 17 Medicare prescriptions for Estradiol (Once Weekly), about the same volume as the typical Connecticut prescriber of this medication (17). Medicare paid an average of $80.36 per fill, versus $114.07 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 26 30-Day Fills standardized to 30-day supplies 760 Days of Medication total across all patients in 2023 | |||
| Clobetasol Propionate | 13 | $47.00▼ below CT avg | ▼ Less than typical |
About Clobetasol Propionate: This medication is used to treat a variety of skin conditions (such as eczema, psoriasis, dermatitis, allergies, rash). Show more ▾ Clobetasol reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a very strong (super-high-potency) corticosteroid. A derivative of PREDNISOLONE with high glucocorticoid activity and low mineralocorticoid activity. Absorbed through the skin faster than FLUOCINONIDE, it is used topically in treatment of PSORIASIS but may cause marked adrenocortical suppression. In 2023, this provider wrote 13 Medicare prescriptions for Clobetasol Propionate, about a third of the volume of the typical Connecticut prescriber of this medication (32). Medicare paid an average of $47.00 per fill, versus $65.04 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 15 30-Day Fills standardized to 30-day supplies 273 Days of Medication total across all patients in 2023 | |||
| Estradiol (Twice Weekly)Estradiol | 12 | $89.82▼ below CT avg | ▼ Less than typical |
About Estradiol (Twice Weekly): This medication is a female hormone (estrogen). Show more ▾ It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. In 2023, this provider wrote 12 Medicare prescriptions for Estradiol (Twice Weekly), about 60% of the volume of the typical Connecticut prescriber of this medication (20). Medicare paid an average of $89.82 per fill, versus $134.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 19.2 30-Day Fills standardized to 30-day supplies 560 Days of Medication total across all patients in 2023 | |||
| PremarinEstrogens, Conjugated | 11 | $575.98 | ▼ Less than typical |
About Premarin: This medication is a female hormone. Show more ▾ It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. Certain estrogen products may also be used by men and women to treat cancers (certain types of prostate cancer, breast cancer that has spread to other parts of the body) and by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). A pharmaceutical preparation containing a mixture of water-soluble, conjugated estrogens derived wholly or in part from URINE of pregnant mares or synthetically from ESTRONE and EQUILIN. It contains a sodium-salt mixture of estrone sulfate (52-62%) and equilin sulfate (22-30%) with a total of the two between 80-88%. Other concomitant conjugates include 17-alpha-dihydroequilin, 17-alpha-estradiol, and 17-beta-dihydroequilin. The potency of the preparation is expressed in terms of an equivalent quantity of sodium estrone sulfate. In 2023, this provider wrote 11 Medicare prescriptions for Premarin, about half the volume of the typical Connecticut prescriber of this medication (20). Medicare paid an average of $575.98 per fill, versus $442.72 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 29 30-Day Fills standardized to 30-day supplies 870 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for JANINE MARIE POPOT M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Obstetrics & Gynecology prescribing approach at this Darien, CT practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among CT prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
